Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a case

Introduction. Conducting research during disease outbreaks can be ethically challenging as evidenced in the 2014-2016 Ebola outbreak in West Africa and COVID-19 pandemic. Yet, there has been little empirical research conducted for understanding the views and perspectives of different stakeholders r...

Full description

Bibliographic Details
Main Authors: Raji Tajudeen, Blessing Silaigwana, Alexei Yavlinsky, Sarah Edwards
Format: Article
Language:English
Published: PAGEPress Publications 2023-09-01
Series:Journal of Public Health in Africa
Subjects:
Online Access:https://jphia.btvb.org/jphia/article/view/1632
_version_ 1797671647453380608
author Raji Tajudeen
Blessing Silaigwana
Alexei Yavlinsky
Sarah Edwards
author_facet Raji Tajudeen
Blessing Silaigwana
Alexei Yavlinsky
Sarah Edwards
author_sort Raji Tajudeen
collection DOAJ
description Introduction. Conducting research during disease outbreaks can be ethically challenging as evidenced in the 2014-2016 Ebola outbreak in West Africa and COVID-19 pandemic. Yet, there has been little empirical research conducted for understanding the views and perspectives of different stakeholders regarding ethical issues in conducting research during disease outbreaks. Objectives. This preliminary study was conducted to empirically explore African public health research stakeholders’ views about research ethics issues during infectious disease outbreaks in Africa. Design. We conducted an online survey of 330 participants attending the International Conference on Re-emerging and Emerging Infectious Disease (ICREID) meeting that took place from 13-15 March 2019 in Addis Ababa, Ethiopia to elicit their views on various research ethics complexities experienced in the 2014 Ebola outbreak. Results. Study results revealed some divergent views on several ethical themes including: ethics of using unregistered interventions in outbreaks; acceptable study design; ethics review processes; risks-benefit assessment; exclusion of pregnant women and children; and biological sample and data sharing. Majority (76.3%) of respondents felt that in the absence of available standard treatments or prevention modalities, the use of investigational interventions can be ethically justifiable if there is a strong scientific rationale and favorable risk-benefit ratio. Regarding conventional placebo-controlled trials during outbreaks with high case fatality rates, respondents that considered this unethical were more than three times those that felt such design were ethically justifiable. We were somewhat surprised that a majority (almost 60%) of respondents were satisfied with the exclusion of pregnant women and children in clinical trials during outbreaks. All respondents concurred with the prioritization of informed consent for research during an outbreak. Conclusions. Based on our findings, research ethics guidance is needed to equip research stakeholders in dealing with ethical complexities arising in the conduct of research during emerging disease outbreaks - especially regarding using experimental interventions; placebo trial design; inclusion or justified exclusion of pregnant women and children; and biological sample/data sharing. The findings will be used in ongoing efforts of developing a consultative and coherent African-centric framework to support ethical conduct of research for future emerging infectious disease outbreaks in Africa.
first_indexed 2024-03-11T21:18:35Z
format Article
id doaj.art-181e5a0a363a46d2b79300a1e3e51706
institution Directory Open Access Journal
issn 2038-9922
2038-9930
language English
last_indexed 2024-03-11T21:18:35Z
publishDate 2023-09-01
publisher PAGEPress Publications
record_format Article
series Journal of Public Health in Africa
spelling doaj.art-181e5a0a363a46d2b79300a1e3e517062023-09-28T10:49:17ZengPAGEPress PublicationsJournal of Public Health in Africa2038-99222038-99302023-09-0114910.4081/jphia.2023.1632Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a caseRaji Tajudeen0Blessing Silaigwana1Alexei Yavlinsky2Sarah Edwards3African Union, Africa CDC, Division of Public Health Institutes and Research, Addis AbabaNIHR Group Tackling Infections to Benefit Africa (TIBA), University of EdinburghUniversity College London, Institute of Health Informatics, LondonUniversity College London, Science & Technology Studies, Bloomsbury, London Introduction. Conducting research during disease outbreaks can be ethically challenging as evidenced in the 2014-2016 Ebola outbreak in West Africa and COVID-19 pandemic. Yet, there has been little empirical research conducted for understanding the views and perspectives of different stakeholders regarding ethical issues in conducting research during disease outbreaks. Objectives. This preliminary study was conducted to empirically explore African public health research stakeholders’ views about research ethics issues during infectious disease outbreaks in Africa. Design. We conducted an online survey of 330 participants attending the International Conference on Re-emerging and Emerging Infectious Disease (ICREID) meeting that took place from 13-15 March 2019 in Addis Ababa, Ethiopia to elicit their views on various research ethics complexities experienced in the 2014 Ebola outbreak. Results. Study results revealed some divergent views on several ethical themes including: ethics of using unregistered interventions in outbreaks; acceptable study design; ethics review processes; risks-benefit assessment; exclusion of pregnant women and children; and biological sample and data sharing. Majority (76.3%) of respondents felt that in the absence of available standard treatments or prevention modalities, the use of investigational interventions can be ethically justifiable if there is a strong scientific rationale and favorable risk-benefit ratio. Regarding conventional placebo-controlled trials during outbreaks with high case fatality rates, respondents that considered this unethical were more than three times those that felt such design were ethically justifiable. We were somewhat surprised that a majority (almost 60%) of respondents were satisfied with the exclusion of pregnant women and children in clinical trials during outbreaks. All respondents concurred with the prioritization of informed consent for research during an outbreak. Conclusions. Based on our findings, research ethics guidance is needed to equip research stakeholders in dealing with ethical complexities arising in the conduct of research during emerging disease outbreaks - especially regarding using experimental interventions; placebo trial design; inclusion or justified exclusion of pregnant women and children; and biological sample/data sharing. The findings will be used in ongoing efforts of developing a consultative and coherent African-centric framework to support ethical conduct of research for future emerging infectious disease outbreaks in Africa. https://jphia.btvb.org/jphia/article/view/1632Research ethics, epidemic outbreaks, emerging infectious diseases, ethical issues, Africa
spellingShingle Raji Tajudeen
Blessing Silaigwana
Alexei Yavlinsky
Sarah Edwards
Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a case
Journal of Public Health in Africa
Research ethics, epidemic outbreaks, emerging infectious diseases, ethical issues, Africa
title Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a case
title_full Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a case
title_fullStr Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a case
title_full_unstemmed Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a case
title_short Research ethics during infectious disease outbreaks: a survey of African research stakeholders using the Ebola virus disease outbreak as a case
title_sort research ethics during infectious disease outbreaks a survey of african research stakeholders using the ebola virus disease outbreak as a case
topic Research ethics, epidemic outbreaks, emerging infectious diseases, ethical issues, Africa
url https://jphia.btvb.org/jphia/article/view/1632
work_keys_str_mv AT rajitajudeen researchethicsduringinfectiousdiseaseoutbreaksasurveyofafricanresearchstakeholdersusingtheebolavirusdiseaseoutbreakasacase
AT blessingsilaigwana researchethicsduringinfectiousdiseaseoutbreaksasurveyofafricanresearchstakeholdersusingtheebolavirusdiseaseoutbreakasacase
AT alexeiyavlinsky researchethicsduringinfectiousdiseaseoutbreaksasurveyofafricanresearchstakeholdersusingtheebolavirusdiseaseoutbreakasacase
AT sarahedwards researchethicsduringinfectiousdiseaseoutbreaksasurveyofafricanresearchstakeholdersusingtheebolavirusdiseaseoutbreakasacase